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A B S T R A C T
The frequency of obesity has risen dramatically in recent years but only few effective and safe drugs are
available. We investigated if green-plant membranes, previously shown to reduce subjective hunger and
promote satiety signals, could affect body weight when given long-term. 38 women (40–65 years of age,
bodymass index 25–33 kg/m2) were randomized to dietary supplementation with either green-plant mem-
branes (5 g) or placebo, consumed once daily before breakfast for 12 weeks. All individuals were in-
structed to follow a three-meal paradigm without any snacking between the meals and to increase their
physical activity. Body weight change was analysed every third week as was blood glucose and various
lipid parameters. On days 1 and 90, following intake of a standardized breakfast, glucose, insulin and
glucagon-like peptide 1 (GLP-1) in plasma were measured, as well as subjective ratings of hunger, satiety
and urge for different palatable foods, using visual analogue scales. Subjects receiving green-plant mem-
branes lost signiﬁcantly more body weight than did those on placebo (p < 0.01). Mean weight loss with
green-plant extract was 5.0 ± 2.3 kg compared to 3.5 ± 2.3 kg in the control group. Consumption of green-
plant membranes also reduced total and LDL-cholesterol (p < 0.01 and p < 0.05 respectively) compared
to control. Single-meal tests performed on day 1 and day 90 demonstrated an increased postprandial
release of GLP-1 and decreased urge for sweet and chocolate on both occasions in individuals supple-
mented with green-plant membranes compared to control. Waist circumference, body fat and leptin de-
creased in both groups over the course of the study, however there were no differences between the groups.
In conclusion, addition of green-plant membranes as a dietary supplement once daily induces weight
loss, improves obesity-related risk-factors, and reduces the urge for palatable food. The mechanism may
reside in the observed increased release of GLP-1.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Overweight subjects have an increased liking for palatable food
(Blundell & MacDiarmid, 1997; Ettinger, Duizer, & Caldwell, 2012),
inducing hyperphagia and the obese state. Whether this is a cause
or a consequence of obesity is not known (Berthoud& Zheng, 2012).
Gut hormones have been demonstrated to regulate the liking and
wanting of sweet and fatty foods, ghrelin acting to stimulatewanting
(Egecioglu et al., 2010) andGLP-1 to suppress liking (Shin et al., 2008).
A common adaptive response upon weight loss by dieting in the
obese is an increased hunger and liking for palatable food, in part
due to reduced secretion of satiety hormones, like leptin and GLP-1
(Adam, Jocken, & Westerterp-Plantenga, 2005; Blundell & Gillett,
2001). However, bariatric surgery does not trigger the same re-
sponse. Instead a diminished preference for sweet and fatty foods
is observed along with a reduction in ghrelin secretion and an in-
crease in the secretion of GLP-1 and PYY (Miras et al., 2012). The
increase in satiety hormone secretion from the distal small intes-
tine following bariatric surgery is partly explained by food diges-
tive products directly reaching the distal part of the small intestine.
We have found that retardation of fat digestion through revers-
ible pancreatic lipase/colipase inhibition by chlorophyll-containing
membranes found in green plants, leads to increased satiety and
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an elevated release of the gut satiety hormone CCK in response to
a high fat diet (Albertsson et al., 2007; Kohnke et al., 2009). In man,
the uptake of fatty acids into the circulation is retarded (Kohnke
et al., 2009), supporting a delay of fatty acid absorption. In addi-
tion to increased satiety following intake of a meal high in fat
(Kohnke et al., 2009), green-plant membranes reduce hunger after
a carbohydrate-rich meal, with a mechanism suggesting a release
of incretin hormones (Stenblom et al., 2013). Long-term studies in
rat and mouse have demonstrated that daily consumption of green-
plantmembranes reduced bodyweight gain, body fatmass and blood
lipid levels (Kohnke et al., 2009) (Montelius et al., 2013). The effects
of long-term treatment with green-plant membranes in humans are
unknown.
The chlorophyll-containing parts of the green plant cell, called
thylakoids, contain a hundred different membrane proteins,
galactolipids and sulpholipids as well as various vitamins (A, E and
K) and antioxidants like carotenoids, lutein, zeaxantin and chloro-
phyll. They are thus a mixture of bioactive compounds that could
be responsible for the retardation of fat digestion previously de-
scribed (Albertsson et al., 2007). Most importantly, following in-
gestion of the green-plant membranes, fat digestion is prolonged,
but nevertheless complete, and in the end the thylakoids them-
selves are also digested. Therefore, no steatorrea or rapid excre-
tion of fat is seen following intake of green-plant membranes, in
contrast to the effects of irreversible lipase inhibitors (Goedecke,
Barsdorf, Beglinger, Levitt, & Lambert, 2003).
In this study we were interested to ﬁnd out if long-term treat-
ment with green-plantmembranes through its satiating effects could
affect body weight and metabolic parameters related to obesity. We
were also interested in measuring the release of GLP-1, a gut
hormone promoting satiety (Flint, Raben, Astrup, & Holst, 1998;
Holst, 2007). Based on the fact that GLP-1 regulates reward-
induced behaviour for food (Dickson et al., 2012; Egecioglu, Engel,
& Jerlhag, 2013a, 2013b; Egecioglu et al., 2013), the urge for sweet,
salt and fat was evaluated during one day meal tests in the begin-
ning and the end of the study.
Materials and methods
Subjects
Fifty-three healthy non-smoking women, aged 40–65 years, with
a BMI between 25 and 33 were recruited through public advertise-
ment and volunteered for screening, after which 38 women were
enrolled in the study (detailed ﬂow chart, Supplementary Fig. S1).
The exclusion criteria were diabetes, food allergies, irritable bowel
syndrome, food intolerance and recent use of antibiotics. The sub-
jects were not vegetarian and had not followed any diet for the last
three months. Baseline characteristics of the 38 women are shown
in Table 1.
Experimental study design
The study was conducted at the Overweight and Diabetes Unit
and at the Division of Occupational and Environmental Medicine,
Skåne University Hospital (SUS), Lund, Sweden, and designed as a
single-blinded, single-centered, randomized and placebo-controlled,
12-week diet intervention study. The participants were divided into
two groups (n = 19 per group) by a non-algorithmic randomiza-
tion method (ballot, performed by CM). Normal distribution within
and between the groups based on body weight, BMI, blood glucose,
insulin, triacylglycerol (TG) and cholesterol (total and LDL) was con-
ﬁrmed after randomization.
Every third week the participants arrived to the laboratory in
the morning for anthropometric measurements and blood sam-
pling in the fasted state. Waist circumference was measured with
a non-stretchable tape, and body weight, fat-mass and fat free mass
(FFM) were measured with a body composition analyser (TANITA-
BC 418 MA, Amsterdam, The Netherlands). Fasting blood samples
were taken through a venous catheter in the arm.
For meal studies the subjects arrived to the laboratory in the
morning in the fasted state on day 1 and day 90 of the supplemen-
tation period. After ﬁlling in questionnaires, a venous catheter was
inserted in the arm for blood sampling. Thereafter, the subjects re-
ceived a 50 g blueberry drink with or without 5 g of green-plant
membranes. Fiveminutes later, a standardized breakfastwas served
consisting of vanilla yoghurt,muesli, bread, butter, cheese, juice and
coffee or tea (Table 2). Themacronutrient composition of the break-
fast was 60 E% carbohydrate, 28 E% fat and 12 E% protein. The sub-
jects were instructed to eat all the food within 15 minutes.
Venous blood samples for glucose, insulin, ghrelin and GLP-1 anal-
yses were taken at time point zero, ie prior to breakfast, and there-
after at 15, 30, 45, 60, 90, 120, 180, 240, 300 and 360minutes. Blood
samples were collected in chilled 6 mL Vacutainer EDTA-plasma
tubes for all analyses, with the addition of 100 μL DPP-IV inhibitor
(Cat # DPP4-010; Millipore Corp. Billerica, MA, USA) for GLP-1 anal-
ysis. The tubes were centrifuged at 4 °C, and plasma was immedi-
ately stored at –80 °C until analysis.
At time point 360minutes lunch was served consisting of a pizza
(Grandiosa Extra Godfather, Procordia AB, Eslöv, Sweden), water and
coffee/tea. The subjects were told to eat and drink until satisﬁed.
Thereafter the subjects left the laboratory. At time point 660minutes
Table 1
Anthropometric, body composition and fasting serum parameters at baseline and at the end of the study. A decrease in body weight, BMI, FFM (fat free mass), body fat, %
body fat, waist and leptin concentrations was found over the course of the study. Alterations in body weight were dependent on treatment. Fasting glucose and insulin did
not change during the study.
Control group Thylakoid group
Baseline
(n = 19)
End of study
(n = 17)
Change (n = 17)
start end
Baseline
(n = 19)
End of study
(n = 19)
Change (n = 19)
start end
Age (yrs) 54.6 ± 7.5 50.7 ± 7.0
Body weight (kg) 80.2 ± 8.2 76.3 ± 8.9a,b −3.5 ± 2.3 79.9 ± 10.8 75.0 ± 10.5a,b −5.0 ± 2.3
BMI (kg/m2) 28.6 ± 2.3 27.6 ± 2.7a −0.7 ± 0.6 28.9 ± 2.2 27.1 ± 2.2a −1.0 ± 0.5
FFM (kg) 47.6 ± 3.2 46.8 ± 3.3a −0.6 ± 1.1 47.6 ± 4.9 46.3 ± 4.7a −1.3 ± 1.4
Body fat (kg) 32.6 ± 6.2 29.5 ± 6.8a −2.9 ± 1.9 32,3 ± 6,8 28.7 ± 7.0a −3.7 ± 2.5
Body fat (%) 40.4 ± 4.1 38.2 ± 4.9a −2.4 ± 2.1 40.1 ± 4.0 37.8 ± 4.8a −2.3 ± 2.3
Waist (cm) 97.6 ± 9.6 93.3 ± 8.6a −4.4 ± 3.5 93.9 ± 6.7 88.0 ± 7.2a −5.9 ± 3.5
Insulin (mIE/L) 10.6 ± 5.0 9.1 ± 4.5 −0.2 ± 3.4 8.4 ± 4.0 8.3 ± 3.5 −0.1 ± 3.4
Glucose (mmol/L) 5.30 ± 0.50 5.24 ± 0.47 −0.08 ± 0.26 5.34 ± 0.69 5.1 ± 0.56 −0.24 ± 0.46
Leptin (ng/mL) 44.0 ± 22.6 32.3 ± 22.1a −10.5 ± 12.2 42.9 ± 17.7 29.2 ± 17.0a −13.7 ± 17.2
a Effect of time, p < 0.001, two-way RM ANOVA.
b Time and treatment interaction, p < 0.05, two-way RM ANOVA.
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the participants consumed a third meal, consisting of salmon and
potatoes (Laxpytt, Findus AB, Eslöv, Sweden).
Green-plant membranes
The green-plant membranes (thylakoids) used in the present
study was provided by Greenleaf Medical AB, Stockholm, Sweden,
prepared from baby spinach leaves using the pH-method, as de-
scribed (Emek et al., 2010), followed by drum drying. 100 g of green-
plant membranes contain 23.5 g protein, 11.9 g fat, 41.7 g
carbohydrate, 3.5 g salt, 3000mg chlorophyll, 27.9mg lutein, 730 ug
zeaxantin, 4 760 ug betakaroten, 21 ug vitamin A, 1313 ug vitamin
K, 6.07 mg vitamin E and 166 ug folic acid.
The green-plant membranes were mixed with 2.8 g rapeseed oil
(Zeta, Di Luca & Di Luca AB, Stockholm, Sweden) and 50 g of blue-
berry soup (Ekströms original, Procordia Food AB, Eslöv, Sweden)
and given to the participants from day 1. The control group re-
ceived 2.8 g rapeseed oil mixed with 50 g blueberry soup. The blue-
berry drinkswith andwithout the green-plantmembranes contained
209 kJ/50 kcal versus 188 kJ/45 kcal respectively. The blueberry drinks
were taken before breakfast every day.
Diet regimen
In the period between the test-days (days 1 and 90) the partici-
pants were told, besides taking the daily blueberry drink with or
without green-plant membranes, to consume threemeals a day con-
taining a large quantity of vegetables and fruit, and to avoid sweet
drinks and snacks. They were also told to exercise at low intensity
30 minutes each day.
Questionnaires
Questionnaires constructed as Visual Analogue Scale (VAS)
(Flint, Raben, Blundell, & Astrup, 2000) were used to measure sen-
sations of hunger, fullness and urge for speciﬁc food items during
the whole day on the ﬁrst and last days of the study. The question-
naires were ﬁlled in at time points 0, 15, 60, 120, 180, 240, 300 and
360minutes, when lunch was served, and thereafter at time points
420, 480, 540, 600 and 660 min. The VAS-questionnaires included
pictures, to facilitate the evaluation of the urge for speciﬁc food items.
For high carbohydrate snack a picture of a sandwich was pre-
sented; for salt a picture of potato chips; for sweet a picture of candy
and for fat and sweet; a picture of chocolate was presented. Written
instructions were given on the front page of the questionnaire, and
each subject was individually instructed in how to ﬁll out the ques-
tionnaire to avoid misinterpretation. Questions were followed by
a 100mm line anchored by descriptors on each side of the line. Sub-
jects were instructed to place a vertical line across the scale, thus
rating how strong their sensations were at every time point. Ratings
were scored as mm between “not at all” and the individual sub-
jects mark.
Biochemical analyses
Glucose, insulin, TG, cholesterol (total, LDL and HDL) in blood
were analysed by standard methods at the Department of Clinical
Chemistry at Skåne University Hospital (Lund, Sweden). Leptin was
measured with a RIA human/multi species kit using the double
antibody/PEG technique (XL-85K, Millipore Corporation, Billerica,
MA, USA). Active GLP-1 was measured using EGLP-35K (Millipore,
Molsheim, France) and for measures of total ghrelin, EZGRT-89K
(Millipore, Molsheim, France) was used.
Ethics
The Ethics Committee in Lund, Sweden approved the study (2006/
361). The trial was conducted in accordance with the Declaration
of Helsinki. All subjects gave written and oral consent before the
study began.
Statistics
Participants were included in each analysis by original as-
signed groups. All statistical analyses were done using the Prism
version 6, statistical software (GraphPad Software, Inc, San Diego,
CA, USA). Anthropometric measures and fasting leptin, insulin,
glucose and cholesterol concentrations over the course of the study
were analysed by two-way repeated measures (RM) ANOVA. Dif-
ferences at individual time points and changes from baseline at the
end of the study were analysed with unpaired t-test. Area under
the curve (AUC), time to peak value, increase peak value versus base-
line (%) and baseline values for glucose, insulin, ghrelin and GLP-1
during days 1 and 90 were analysed by unpaired t-test or Mann–
Whitney U test.
The variations in VAS ratings over timewere analysedwith a two-
way RM ANOVA in order to test time, treatment and time × treat-
ment interaction for the ﬁrst and the last day respectively. Differences
in VAS at individual time points were analysed with unpaired t-tests.
In ﬁgures and text data are expressed as mean ± SE or for peak
times as median followed by interquartile range. Statistics are based
onMann–Whitney U test if not otherwise stated. p-values <0.05were
considered statistically signiﬁcant.
Results
All 38 participants are included in the statistical analysis of sub-
jective appetite and hormonal release on day 1. One participant did
not follow the dietary and exercise recommendations given and one
individual moved abroad during the study and were therefore not
included in the statistical analysis at day 90 or in the analysis of
longitudinal changes.
Body weight, anthropometric and plasma parameters
Supplementation with green-plant membranes for three months
produced an increased weight loss compared to control (Fig. 1). For
absolute body weight, an interaction between time and treatment
was found over the course of the study (F(4, 136) = 2.94, p < 0.05,
two-way RM ANOVA, Table 1). The ANOVA analysis of weight loss
revealed an effect of treatment (F(1, 34) = 4.18, p < 0.05, two-way
RM ANOVA) and an interaction between time and treatment (F(4,
136) = 2.94, p < 0.05, two-way RM ANOVA, Fig. 1). The weight loss
in the treated group was increased at weeks 6, 9 and 12 (Fig. 1).
Anthropometric measures, FFM, body fat and serum concentra-
tion of fasting leptin decreased in both groups over the course of
Table 2
Composition of the breakfast.
Ingredients Amount Caloric content
Vanilla yoghurt, 2.5% fat 150 g 121,5 kcal
Muesli with tropical fruits 1 dl = 45 g 185 kcal
White bread 1 piece = 40 g 98 kcal
Butter 1 tsp 33 kcal
Cheese, 28% fat 2 pieces = 20 g 77 kcal
Red bell pepper 2 pieces = 20 g 6 kcal
Orange juice 2 dl 86 kcal
Coffee/tea (with 1 tbsp milk 0.5% fat if
preferred)
1 cup ~10 kcal
Blueberry drink (± green-plant membrane
supplement)
50 g 45 kcal
Total 660 kcal
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the study while fasting glucose and insulin were unaltered (Table 1).
No differences between the groups were found (Table 1).
Green-plantmembrane supplementationdecreased total andLDL-
cholesterol compared to control (Fig. 2). An effect of treatment and
an interaction between time and treatmentwere found in total cho-
lesterol (F(1, 34) = 5.07, p < 0.05 and F(4, 136) = 3.83, p < 0.01, re-
spectively). Analysis of individual time points revealed that total
cholesterol was decreased at 3, 6, 9 and 12 weeks in the thylakoid
group compared to control (Fig. 2A). For LDL-cholesterol an effect
of treatmentwas found in theANOVAanalysis (F(1, 34) = 4.62,p < 0.05)
and the levels were decreased at time points 3, 6, 9 and 12 weeks
in the treated group (Fig. 2B). HDL-cholesterol and triglycerideswere
not affected over time or by treatment (Fig. 2C and D).
Glucose, insulin, ghrelin and GLP-1 on day one
In both experimental groups blood glucose increased after break-
fast consumption and reached maximal concentration at median
time point 15 (15–30) min for control and 30 (15–30) min for the
treated group (p = 0.30). The glucose concentration was lower
at time point 15 min in the treated group compared to control
(Fig. 3A).
Plasma insulin increased following breakfast and reached
maximum concentrations at median time point 45 (30–45) min for
control and 45 (30–45) min for the treated group (p = 0.33). Insulin
concentrations were lower at time point 15min in the treated group
compared to controls (Fig. 3B).
GLP-1 concentrations increased following breakfast for both ex-
perimental groups, reaching a ﬁrst peak at median time 15 (15.0–
33.8) min in the control group and 30 (15.0–30.0) min for the treated
group (p = 0.082) (Fig. 4A). A second GLP-1 peak occurred at 90 (90.0–
120.0) min for both groups respectively (p = 0.80). The % maximum
increase versus baseline was 2.6 fold higher for the ﬁrst peak and
1.8 fold higher for the second peak in the treated group compared
to control (Fig. 4D). No differences in GLP-1 concentrations were
found at baseline, in absolute peak value or at any speciﬁc time point
between the treated and the control groups (Fig. 4A and C).
Ghrelin concentrations decreased following breakfast in both ex-
perimental groups (Fig. 4B). Thereafter both curves reverted back
to fasting values at time point 360 min. There was no difference in
ghrelin concentrations at any time point (Fig. 4B).
Glucose, insulin, ghrelin and GLP-1 on day 90
Glucose concentrations following breakfast on day 90were similar
in the control group and in the treated group (Fig. 5A). Maximum
Fig. 1. Body weight loss with and without green-plant membrane supplementa-
tion. Dietary green-plant membranes produced a continuous body weight loss that
was more marked compared to control at the end of the study. Values are Means ± SE.
* p < 0.05, ** p < 0.01, two-way RM ANOVA followed by unpaired t-test.
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Fig. 2. Blood lipid parameters with and without supplementation with green-plant membranes. Green-plant membranes decreased total and LDL-cholesterol while HDL-
cholesterol and TG were unaltered. Values are Means ± SE. * p < 0.05, ** p < 0.01, two-way RM ANOVA followed by unpaired t-tests.
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concentrations were reached at median time point 15 (15–30) min
in the control group and at 30 (15–30) min in the treated group
(p = 0.16).
Insulin concentrations were increased in a similar way in the two
experimental groups after breakfast on the last day (Fig. 5B). No dif-
ference in the time to reach maximal concentrations was found
between the groups (control: 30, (30–45) min, treated: 30 (30–
45) min, p = 0.69).
GLP-1 was released after breakfast on day 90 in both experi-
mental groups (Fig. 6A). The concentrations of GLP-1 were similar
at baseline and increased at time points 30, 45 and 60 min in the
treated group compared to control as was the AUC0–60 (control: 393.1;
290.1–595.1, treated: 565.2; 448.37–747.61, p = 0.039). Further-
more, the maximum peak value for the initial peak was elevated
in the treated group compared to control while no difference in the
absolute values for the second peak was seen (p = 0.14, Fig. 6C). The
initial GLP-1 peak was reached at median time point 15 (15–30)
min in the control group and at 30 (15–33.75) min in the treated
group (p = 0.10). The second GLP-1 peak occurred at median time
point 120 (90–120) min for the control group and 90 (60–120) min
Fig. 3. Postprandial glucose and insulin day 1. Blood glucose (A) and plasma insulin (B) in response to breakfast served with or without green-plant membranes on the ﬁrst
day of the intervention study. Values are Means ± SE. * p < 0.05, unpaired t-tests.
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Fig. 4. Postprandial GLP-1 and ghrelin day 1. Plasma concentrations of GLP-1 (A), ghrelin (B), baseline and peak values of GLP-1 (C), percentage increase in peak values of
GLP-1 (D) on the ﬁrst day of the study. Values are Means ± SE. * p < 0.05, ** p < 0.01, Mann–Whitney U test.
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in the treated group (p = 0.28). The % maximum difference versus
baseline was not different in the treated group on day 90 com-
pared to control (Fig. 6D).
Ghrelin concentrations were suppressed following breakfast in
both the treated group and the control group (Fig. 6B). Thereafter
the ghrelin concentrations rose to original values at time point
240 min. There was no difference in response between the two
groups (Fig. 6B).
Sensation of hunger, satiety, urge for speciﬁc foods and food intake
on day 1
Subjective ratings for hunger, satiety and urge for speciﬁc food
items on day one are presented in Fig. 7. All VAS-ratings were
inﬂuenced by time (p < 0.001 respectively, two-way RM ANOVA)
such that hunger and urge for speciﬁc food items were increased
before mealtime and to a varied extent decreased following meals
Fig. 5. Postprandial glucose and insulin day 90. Blood glucose (A) and plasma insulin (B) concentrations following breakfast on day 90. Values are Means ± SE.
Fig. 6. Postprandial GLP-1 and ghrelin day 90. Plasma concentrations of GLP-1 (A), ghrelin (B), baseline and peak values of GLP-1 (C) and percentage increase in peak values
of GLP-1 (D) in response to a breakfast on the last day of the intervention study in overweight women. Values are Mean ± SE. * p < 0.05, ** p < 0.01, Mann–Whitney U test.
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while ratings of satiety demonstrated the opposite curve (Fig. 7A
and B). There was also an effect of treatment on the ratings for the
urge for sweet and chocolate (sweet; F (1, 36) = 5.79, p < 0.05 and
chocolate; F (1, 36) = 5,892, p < 0.05, two-way RM ANOVA, Fig. 7C
and D). The urge for sweet was lower in the treated group at the
time point prior to lunch and remained lower for the following
3 hours compared to control. Ratings for chocolate were lower im-
mediately following lunch in the treated group and remained lower
in the following 3 hours compared to the controls. In contrast, the
ratings of hunger, satiety, urge for a high carbohydrate snack or
salt were not different between the treated and the control groups
(Fig. 7A, B, E and F). No time by treatment interaction was found
in any of the VAS ratings on day 1. Total caloric intake during day
1, excluding the standardized breakfast, was similar between the
groups (control: 1366 ± 48 kcal, green-plant membranes:
1270 ± 65 kcal, p = 0.24, unpaired t-test).
Sensation of hunger, satiety and urge for speciﬁc foods on day 90
Subjective ratings for hunger, satiety and urge for speciﬁc food
items on day 90 are presented in Fig. 8. An effect in ratings over time
was found for all VAS measures (p < 0.001 respectively, two-way RM
ANOVA). Similar to day one there was an effect of treatment on the
ratings for the urge for chocolate (F (1, 34) = 6.2, p < 0.01, two-way
RM ANOVA, Fig. 8D). Furthermore, a time by treatment interac-
tionwas found for both the urge for sweet (F (16, 544) = 1.88, p = 0.05,
two-way RM ANOVA) and for the urge for chocolate (F (16,
544) = 1.91, p < 0.05, two-way RM ANOVA). The urge for sweet and
fat/sweet (chocolate) was lower in the treated group prior to lunch
on day 90 and remained low in the treated group for the rest of the
duration of the session compared to control. The ratings of the urge
for a high carbohydrate snack or salt were not different between
the treated and the control groups (Fig. 8E and F). Caloric intake
Fig. 7. Hunger, satiety and urge for palatable food day 1. VAS ratings of hunger (A), satiety (B) and urge for sweets (C), chocolate (D), sandwich (E) and chips (F) during day
1. Values are given as Mean ± SE. * p < 0.05, ** p < 0.01, *** p < 0.001, two-way RM ANOVA followed by unpaired t-tests.
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during day 90, excluding the standardized breakfast, was similar
between the groups (control: 1241 ± 55 kcal, green-plant mem-
brane: 1297 ± 104 kcal, p = 0.65, unpaired t-test).
No adverse events or effects were reported in any of the groups.
Discussion
In this study we demonstrated for the ﬁrst time that green-
plant membranes, when added to the diet daily for three months,
markedly reduced body weight in overweight women. In addi-
tion, total and LDL-cholesterol levels were reduced compared to
control. These ﬁndings are supported by animal studies, where body
weight loss and blood lipid lowering effects have been observed
(Kohnke et al., 2009; Montelius et al., 2013).
The mechanism underlying the effect of green-plant mem-
branes to reduce body weight was investigated by two test-meals,
one at the start and one at the end of the study. These demon-
strated a reduced urge for sweet and fatty foods. The decreased
urge following treatment was apparent already on day 1, as well
as on day 90, indicating both an immediate and a sustained
effect of green-plant membranes. We also observed an increased
release in GLP-1 postprandially both on day 1 and day 90, suggest-
ing that green-plant membranes inﬂuence pathways that are
important for satiety and for the determination of the reward
value of food. Furthermore, given that diet-induced weight loss
has been shown to reduce postprandial GLP-1 levels (Jarry et al.,
2006), it is remarkable that the increased secretion of GLP-1 in
the treated group was sustained during weight loss in the present
study.
The effect of green-plant membranes on body weight loss (6.3%)
after 12 weeks was comparable to the effect of treatment with the
GLP-1 analogue liraglutide (Astrup et al., 2009). Thus increasing the
endogenous release of GLP-1 may be as eﬃcient for obesity treat-
ment as pharmacological agents. It is very likely however that treat-
ment with green-plant membranes involves other additional
mechanisms for body weight reduction.
Fig. 8. Hunger, satiety and urge for palatable food day 90. VAS ratings of hunger (A), satiety (B) and urge for sweets (C), chocolate (D), sandwich (E) and chips (F) during the
last day of the intervention study. Values are given as Mean ± SE. * p < 0.05, ** p < 0.01, *** p < 0.001, two-way RM ANOVA followed by unpaired t-tests.
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Palatability and pleasantness are important determinants of what
and howmuch we eat (Erlanson-Albertsson, 2005). Increased intake
of energy-dense food high in fat and sugar adds energy but also dis-
rupts functions in the brain controlling appetite and motivation
(Berthoud, 2012). In the control group the urge for palatable food
increased prior to lunch, was reduced following lunch and there-
after reverted. With consumption of green-plant membranes a de-
creased urge for palatable food was noted prior to lunch, which
persisted following lunch despite no further consumption of green-
plant membranes. The mechanism may be related to the in-
creased release of GLP-1.
Release of GLP-1 from enteroendocrine L-cells in the distal in-
testine occurs through nutrients present in the lumen of the intes-
tine and is dependent on the nutrient composition. The most potent
secretagogues for GLP-1 are carbohydrate and fat. The release of
GLP-1 following administration of pure glucose results in one peak,
occurring at around 15 min after oral glucose load (Steinert et al.,
2011). Following consumption of a mixed diet with carbohydrate,
fat and protein the release of GLP-1 may be twofold, one early peak
at time point 15 minutes and one later peak, at 90 minutes. Rapid
release of GLP-1 occurs through neuronal activation and/or endo-
crine factors of the proximal-distal loop of the intestine and the
second peak through direct interaction of nutrients with the
enteroendocrine L-cells in the distal ileum.
In the present study the peak concentrations of initial GLP-1
release occurred at time point 30 min in the treated group and at
15 min in the control group, suggesting that the green-plant mem-
branes may interfere with factors that stimulate rapid GLP-1 release.
The second peak of GLP-1 was also increased on day 1 in the treated
group. A possible mechanism for these effects of the green-plant
membranes to increase GLP-1 secretion could be related to CCK. In-
gestion of green-plant membranes has been found to release CCK,
demonstrated both in rodents and in man (Kohnke et al., 2009) and
the importance of CCK for mediating GLP-1 release is supported by
studies where blockade of CCK-receptors markedly reduced fatty
acid-stimulated GLP-1 secretion (Beglinger et al., 2010). Further-
more, the green-plant membranes retard fat digestion without
causing an irreversible lipase inhibition (Albertsson et al., 2007). This
is important, since hydrolysis of fat is required for the GLP-1 re-
leasing effects of fat and free fatty acid infusion directly into the in-
testinal lumen cause a substantial release of GLP-1 (Beglinger et al.,
2010). In contrast, orlistat, that irreversibly inhibits fat digestion,
leads to a lower release of GLP-1 and CCK (Beglinger & Degen, 2004;
Ellrichmann et al., 2008). The mechanism for the green-plant
membrane-induced GLP-1 release could thus be a direct luminal
effect of fatty acids on enteroendocrine cells via prolonged diges-
tion and absorption of dietary fat and/or an indirect effect medi-
ated through neurohumoral signals such as CCK. In rodents green-
plant membranes have been demonstrated to act in a pre-biotic way,
changing the intestinal microﬂora. The release of GLP-1 by these
bacterial products via short chain fatty acids (Yadav, Lee, Lloyd,
Walter, & Rane, 2013) may be an additional explanation for the sus-
tained effect of green-plant membranes over time.
Various mechanisms inﬂuence reward in relation to food, among
these are gut appetite hormones, such as ghrelin (Abizaid et al.,
2006; Egecioglu et al., 2010; Jerlhag et al., 2006; Merkestein et al.,
2012; Skibicka, Hansson, Egecioglu, & Dickson, 2012) and GLP-1
(Alhadeff, Rupprecht, & Hayes, 2012; Dickson et al., 2012). Ana-
logues of GLP-1 have been shown to decrease preference and con-
sumption for palatable foods in both humans and rodents (Inoue
et al., 2011; Raun et al., 2007; Zhang et al., 2013). These studies
have been extended to demonstrate that GLP-1 analogues sup-
press sucrose-induced reward and motivation in rats (Dickson et al.,
2012). Furthermore, blockade of GLP-1 receptor signalling dimin-
ishes food reward-related behaviour in rats indicating that endog-
enous GLP-1 signalling is involved in the regulation of food reward
(Alhadeff et al., 2012). The effect of green-plantmembranes to reduce
the urge for sweet and fat may thus be linked to the elevation of
GLP-1 concentrations and/or alterations of peak GLP-1 levels. Ghrelin
is known to stimulate reward-related behaviour and food
preference (Egecioglu et al., 2010; Merkestein et al., 2012).
Green-plant membranes have previously been demonstrated to
decrease ghrelin concentrations in humans and pigs (Kohnke
et al., 2009; Montelius et al., 2013) indicating that ghrelin signal-
ling may also be involved in the regulation of urge for palatable
food by green-plant membranes. However, in this study we did
not ﬁnd any effects on ghrelin secretion by the green-plant
membranes.
Another general mechanism important for reward seeking, par-
ticularly related to urge for sweet, is glucose and insulin homeo-
stasis, a lowering of blood glucose that leads to search for sweet
food (Figlewicz & Benoit, 2009). In this study we found no pro-
nounced effects on glucose or insulin by the green-plant mem-
branes suggesting that insulin and glucose are not central for the
treatment-induced effects on the urge for palatable foods.
The urge for palatable food tends to increase over the course of
the day and hence any inﬂuence on these urges would be more pro-
nounced in the afternoon. Accordingly, inhibition of the urge for pal-
atable food by green-plant membranes was more evident following
lunch in the present study. This long lasting reduction could be due
to the relative resistance to hydrolysis of green-plant membranes
in the intestine (Emek et al., 2011), thereby inﬂuencing hormonal
release also following lunch. The possible prolonged effect of green-
plant membranes to alter gut hormone secretion after a secondmeal
needs to be further elucidated.
The mechanism for the reduction in blood cholesterol is not
known, but may involve an increased production of bile salt, needed
for the prolonged intestinal fat digestion and fat absorption
(Borgstrom & Erlanson, 1978). The LDL-cholesterol lowering effect
of green-plant membranes is in the magnitude of the bile acid se-
questering therapeutics (Rosenson & Underberg, 2013).
In conclusion, we demonstrate that consumption of chlorophyll-
containing parts of green plants, in overweight patients results in
signiﬁcant weight reduction, and reduction in blood cholesterol to-
gether with a decreased urge for palatable food. Themechanism sug-
gests an increased meal-related GLP-1 release that sustained during
the intervention period. Green-plant membranes may thus be a new
agent for control of appetite and body weight.
References
Abizaid, A., Liu, Z. W., Andrews, Z. B., Shanabrough, M., Borok, E., Elsworth, J. D., et al.
(2006). Ghrelin modulates the activity and synaptic input organization of
midbrain dopamine neurons while promoting appetite. The Journal of Clinical
Investigation, 116(12), 3229–3239.
Adam, T. C., Jocken, J., & Westerterp-Plantenga, M. S. (2005). Decreased glucagon-like
peptide 1 release after weight loss in overweight/obese subjects. Obesity Research,
13(4), 710–716.
Albertsson, P. A., Kohnke, R., Emek, S. C., Mei, J., Rehfeld, J. F., Akerlund, H. E., et al.
(2007). Chloroplast membranes retard fat digestion and induce satiety. Effect of
biological membranes on pancreatic lipase/co-lipase. The Biochemical Journal,
401(3), 727–733.
Alhadeff, A. L., Rupprecht, L. E., & Hayes, M. R. (2012). GLP-1 neurons in the nucleus
of the solitary tract project directly to the ventral tegmental area and nucleus
accumbens to control for food intake. Endocrinology, 153(2), 647–658.
Astrup, A., Rossner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., et al.
(2009). Effects of liraglutide in the treatment of obesity. A randomised, double-
blind, placebo-controlled study. Lancet, 374(9701), 1606–1616.
Beglinger, C., & Degen, L. (2004). Fat in the intestine as a regulator of appetite. Role
of CCK. Physiology and Behavior, 83(4), 617–621.
Beglinger, S., Drewe, J., Schirra, J., Goke, B., D’Amato, M., & Beglinger, C. (2010). Role
of fat hydrolysis in regulating glucagon-like peptide-1 secretion. The Journal of
Clinical Endocrinology and Metabolism, 95(2), 879–886.
Berthoud, H. R. (2012). The neurobiology of food intake in an obesogenic environment.
The Proceedings of the Nutrition Society, 71(4), 478–487.
Berthoud, H. R., & Zheng, H. (2012). Modulation of taste responsiveness and food
preference by obesity and weight loss. Physiology and Behavior, 107(4), 527–532.
303C. Montelius et al./Appetite 81 (2014) 295–304
Blundell, J. E., & Gillett, A. (2001). Control of food intake in the obese. Obesity Research,
9(Suppl. 4), 263S–270S.
Blundell, J. E., & MacDiarmid, J. I. (1997). Fat as a risk factor for overconsumption.
Satiation, satiety, and patterns of eating. Journal of the American Dietetic
Association, 97(7 Suppl.), S63–S69.
Borgstrom, B., & Erlanson, C. (1978). Lipase, colipase, amphipathic dietary proteins,
and bile acids. Gastroenterology, 75(4), 766.
Dickson, S. L., Shirazi, R. H., Hansson, C., Bergquist, F., Nissbrandt, H., & Skibicka,
K. P. (2012). The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases
the rewarding value of food. A new role for mesolimbic GLP-1 receptors. Journal
of Neuroscience, 32(14), 4812–4820.
Egecioglu, E., Engel, J. A., & Jerlhag, E. (2013a). The glucagon-like peptide 1 analogue
exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal
dopamine release, conditioned place preference as well as the expression of
locomotor sensitization in mice. PLoS ONE, 8(10), e77284.
Egecioglu, E., Engel, J. A., & Jerlhag, E. (2013b). The glucagon-like peptide 1 analogue,
exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.
PLoS ONE, 8(7), e69010.
Egecioglu, E., Jerlhag, E., Salome, N., Skibicka, K. P., Haage, D., Bohlooly, Y. M., et al.
(2010). Ghrelin increases intake of rewarding food in rodents. Addiction Biology,
15(3), 304–311.
Egecioglu, E., Steensland, P., Fredriksson, I., Feltmann, K., Engel, J. A., & Jerlhag, E.
(2013). The glucagon-like peptide 1 analogue exendin-4 attenuates alcohol
mediated behaviors in rodents. Psychoneuroendocrinology, 38(8), 1259–
1270.
Ellrichmann, M., Kapelle, M., Ritter, P. R., Holst, J. J., Herzig, K. H., Schmidt, W. E., et al.
(2008). Orlistat inhibition of intestinal lipase acutely increases appetite and
attenuates postprandial glucagon-like peptide-1-(7–36)-amide-1, cholecystokinin,
and peptide YY concentrations. The Journal of Clinical Endocrinology and
Metabolism, 93(10), 3995–3998.
Emek, S. C., Akerlund, H. E., Clausen, M., Ohlsson, L., Westrom, B., Erlanson-Albertsson,
C., et al. (2011). Pigments protect the light harvesting proteins of chloroplast
thylakoid membranes against digestion by gastrointestinal proteases. Food
Hydrocolloids, 25(6), 1618–1626.
Emek, S. C., Szilagyi, A., Akerlund, H. E., Albertsson, P. A., Kohnke, R., Holm, A., et al.
(2010). A large scale method for preparation of plant thylakoids for use in body
weight regulation. Preparative Biochemistry & Biotechnology, 40(1), 13–27.
Erlanson-Albertsson, C. (2005). How palatable food disrupts appetite regulation. Basic
and Clinical Pharmacology and Toxicology, 97(2), 61–73.
Ettinger, L., Duizer, L., & Caldwell, T. (2012). Body fat, sweetness sensitivity, and
preference. Determining the relationship. Canadian Journal of Dietetic Practice and
Research: A Publication of Dietitians of Canada, 73(1), 45–48.
Figlewicz, D. P., & Benoit, S. C. (2009). Insulin, leptin, and food reward. Update 2008.
American Journal of Physiology – Regulatory Integrative and Comparative Physiology,
296(1), R9–R19.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998). Glucagon-like peptide 1 promotes
satiety and suppresses energy intake in humans. The Journal of Clinical
Investigation, 101(3), 515–520.
Flint, A., Raben, A., Blundell, J. E., & Astrup, A. (2000). Reproducibility, power and
validity of visual analogue scales in assessment of appetite sensations in single
test meal studies. International Journal of Obesity and Related Metabolic Disorders:
Journal of the International Association for the Study of Obesity, 24(1), 38–48.
Goedecke, J. H., Barsdorf, M., Beglinger, C., Levitt, N. S., & Lambert, E. V. (2003). Effects
of a lipase inhibitor (orlistat) on cholecystokinin and appetite in response to a
high-fat meal. International Journal of Obesity and Related Metabolic Disorders:
Journal of the International Association for the Study of Obesity, 27(12), 1479–
1485.
Holst, J. J. (2007). The physiology of glucagon-like peptide 1. Physiological Reviews,
87(4), 1409–1439.
Inoue, K., Maeda, N., Kashine, S., Fujishima, Y., Kozawa, J., Hiuge-Shimizu, A., et al.
(2011). Short-term effects of liraglutide on visceral fat adiposity, appetite, and
food preference. A pilot study of obese Japanese patients with type 2 diabetes.
Cardiovascular Diabetology, 10, 109.
Jarry, A., Bach-Ngohou, K., Masson, D., Dejoie, T., Lehur, P. A., Mosnier, J. F., et al. (2006).
Human colonic myocytes are involved in postischemic inﬂammation through
ADAM17-dependent TNFalpha production. British Journal of Pharmacology, 147(1),
64–72.
Jerlhag, E., Egecioglu, E., Dickson, S. L., Andersson, M., Svensson, L., & Engel, J. A. (2006).
Ghrelin stimulates locomotor activity and accumbal dopamine-overﬂow via
central cholinergic systems in mice. Implications for its involvement in brain
reward. Addiction Biology, 11(1), 45–54.
Kohnke, R., Lindbo, A., Larsson, T., Lindqvist, A., Rayner, M., Emek, S. C., et al. (2009).
Thylakoids promote release of the satiety hormone cholecystokinin while
reducing insulin in healthy humans. Scandinavian Journal of Gastroenterology,
44(6), 712–719.
Kohnke, R., Lindqvist, A., Goransson, N., Emek, S. C., Albertsson, P. A., Rehfeld, J. F.,
et al. (2009). Thylakoids suppress appetite by increasing cholecystokinin resulting
in lower food intake and body weight in high-fat fed mice. Phytotherapy Research,
23(12), 1778–1783.
Merkestein, M., Brans, M. A., Luijendijk, M. C., de Jong, J. W., Egecioglu, E., Dickson,
S. L., et al. (2012). Ghrelin mediates anticipation to a palatable meal in rats. Obesity
(Silver Spring), 20(5), 963–971.
Miras, A. D., Jackson, R. N., Jackson, S. N., Goldstone, A. P., Olbers, T., Hackenberg, T.,
et al. (2012). Gastric bypass surgery for obesity decreases the reward value of
a sweet-fat stimulus as assessed in a progressive ratio task. The American Journal
of Clinical Nutrition, 96(3), 467–473.
Montelius, C., Osman, N., Weström, B., Ahrné, S., Molin, G., Albertsson, P.-Å., et al.
(2013). Feeding spinach thylakoids to rat modulates the gut microbiota, decreases
food intake and affects the insulin response. Journal of Nutritional Science, 2(e20),
1–9. doi:10.1017/jns.2012.29.
Montelius, C., Szwiec, K., Kardas, M., Lozinska, L., Erlanson-Albertsson, C.,
Pierzynowski, S., et al. (2013). Dietary thylakoids suppress blood glucose and
modulate appetite-regulating hormones in pigs exposed to oral glucose tolerance
test. Clinical Nutrition (Edinburgh, Scotland).
Raun, K., von Voss, P., Gotfredsen, C. F., Golozoubova, V., Rolin, B., & Knudsen, L. B.
(2007). Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body
weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV
inhibitor, vildagliptin, does not. Diabetes, 56(1), 8–15.
Rosenson, R. S., & Underberg, J. A. (2013). Systematic review. Evaluating the effect
of lipid-lowering therapy on lipoprotein and lipid values. Cardiovascular Drugs
and Therapy, 27(5), 465–479.
Shin, Y. K., Martin, B., Golden, E., Dotson, C. D., Maudsley, S., Kim, W., et al. (2008).
Modulation of taste sensitivity by GLP-1 signaling. Journal of Neurochemistry,
106(1), 455–463.
Skibicka, K. P., Hansson, C., Egecioglu, E., & Dickson, S. L. (2012). Role of ghrelin in
food reward. Impact of ghrelin on sucrose self-administration and mesolimbic
dopamine and acetylcholine receptor gene expression. Addiction Biology, 17(1),
95–107.
Steinert, R. E., Gerspach, A. C., Gutmann, H., Asarian, L., Drewe, J., & Beglinger, C. (2011).
The functional involvement of gut-expressed sweet taste receptors in glucose-
stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY).
Clinical Nutrition (Edinburgh, Scotland), 30(4), 524–532.
Stenblom, E. L., Montelius, C., Ostbring, K., Hakansson, M., Nilsson, S., Rehfeld, J. F.,
et al. (2013). Supplementation by thylakoids to a high carbohydrate meal
decreases feelings of hunger, elevates CCK levels and prevents postprandial
hypoglycaemia in overweight women. Appetite, 68, 118–123.
Yadav, H., Lee, J. H., Lloyd, J., Walter, P., & Rane, S. G. (2013). Beneﬁcial metabolic
effects of a probiotic via butyrate-induced GLP-1 hormone secretion. The Journal
of Biological Chemistry, 288(35), 25088–25097.
Zhang, X. J., Wang, Y. Q., Long, Y., Wang, L., Li, Y., Gao, F. B., et al. (2013). Alteration
of sweet taste in high-fat diet induced obese rats after 4 weeks treatment with
exenatide. Peptides, 47, 115–123.
Appendix: Supplementary material
Supplementary data to this article can be found online at
doi:10.1016/j.endend.2013.05.004.
304 C. Montelius et al./Appetite 81 (2014) 295–304
